<?xml version="1.0" encoding="UTF-8"?>




<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Research Updates</title>
    <link>http://www.alsa.org</link>
    <description></description>
    <managingEditor></managingEditor>
    <webMaster></webMaster>
    <copyright></copyright>
    <generator>Convio Content Management System Module</generator>
    <language>en-us</language>

  

  
    <item>
    <guid isPermaLink="false">www.alsa.org-335975404</guid>
    <title>The ALS Association Announces New Research Grants</title>
    <link>http://www.alsa.org/news/the-als-association-announces.html</link>
    <description>The ALS Association is proud to announce seven new research grants that will allow scientists to study several of topics pertinent to The Association&apos;s TREAT ALS Research Portfolio.</description>
    <pubDate>Tue, 15 May 2012 11:01:57 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">www.alsa.org-334168557</guid>
    <title>Drug Company Working Group Meeting Attracts Professionals from Academia and Industry to Discuss Therapeutic Opportunities for ALS</title>
    <link>http://www.alsa.org/news/drug-company-group-12.html</link>
    <description>The ALS Association brought together an overflow crowd of individuals with the common purpose of finding new ALS treatments at The American Academy of Neurology Annual Meeting.</description>
    <pubDate>Mon, 07 May 2012 20:10:22 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">www.alsa.org-319221144</guid>
    <title>ALS Drug Discovery Meeting Forges Partnerships for Faster Drug Development</title>
    <link>http://www.alsa.org/news/archive/als-drug-discovery-meeting.html</link>
    <description>In early March, more than 120 researchers, drug developers and government officials collaborated to discuss ways to accelerate drug discovery to treat ALS. </description>
    <pubDate>Mon, 30 Apr 2012 13:10:48 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">www.alsa.org-332312736</guid>
    <title>The Search for Biomarkers to Speed Drug Discovery</title>
    <link>http://www.alsa.org/news/archive/biomarkers-to-speed.html</link>
    <description>No description available</description>
    <pubDate>Mon, 30 Apr 2012 12:18:34 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">www.alsa.org-332312961</guid>
    <title>Potential New Targets in the Search for Therapy </title>
    <link>http://www.alsa.org/news/archive/potential-new-targets.html</link>
    <description>No description available</description>
    <pubDate>Mon, 30 Apr 2012 12:17:54 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">www.alsa.org-332313951</guid>
    <title>The Current State of Clinical Trials in ALS</title>
    <link>http://www.alsa.org/news/archive/current-therapeutics.html</link>
    <description>No description available</description>
    <pubDate>Mon, 30 Apr 2012 12:16:38 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">www.alsa.org-331232740</guid>
    <title>Request for Proposals - Clinical Management and Research</title>
    <link>http://www.alsa.org/news/archive/rfa-clinical-research.html</link>
    <description>Two open calls for proposals: Clinical Research Pilot Study and Clinical Management Grants. Deadline for brief study outline is May 28, 2012.</description>
    <pubDate>Sun, 29 Apr 2012 13:59:18 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">www.alsa.org-331254136</guid>
    <title>Quest Diagnostics Announces C9orf72 Genetic Test for ALS</title>
    <link>http://www.alsa.org/news/quest-diagnostics-announces.html</link>
    <description>The company&apos;s Athena Diagnostics business unit unveiled the new test at the American Academy of Neurology Annual Meeting this week in New Orleans.</description>
    <pubDate>Thu, 26 Apr 2012 11:10:29 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">www.alsa.org-331192769</guid>
    <title>Cytokinetics Announces Encouraging Results from CK-2017357 Phase II Clinical Trials</title>
    <link>http://www.alsa.org/news/cytokinetics-announces.html</link>
    <description>As reported at the 64th annual meeting of the American Academy of Neurology, Cytokinetics&apos; drug CK-2017357 has been shown to be safe and well-tolerated at different dosage levels when used alone or in combination with riluzole. </description>
    <pubDate>Thu, 26 Apr 2012 09:52:57 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">www.alsa.org-330901870</guid>
    <title>2012 Sheila Essey Award Recipient Recognized at American Academy of Neurology Conference</title>
    <link>http://www.alsa.org/news/2012-sheila-essey-award-1.html</link>
    <description>A clinician scientist with a strong background in molecular cell biology received the prestigious award for ALS research on April 24.</description>
    <pubDate>Wed, 25 Apr 2012 10:37:26 -0500</pubDate>    
    </item>
  
  </channel>
</rss>


